DSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question etc.
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Department and Industry Associations to organize 3 days National Level Expo on Indian Medical Devices Sector at Pragati Maidan, New Delhi between 9-11 Dec 2022, first of its kind expo in India
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
The company will address the observations within a stipulated timeline working with the regulators
There is also a growing interest in whole generation sequencing (WGS)
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
The companies have also initiated a Phase 1/2/3 study NCT05543616 to evaluate the safety, tolerability, and immunogenicity of different doses
The companies will leverage their respective proprietary technology platforms
One in two women with advanced ovarian cancer has an HRD-positive tumor
Subscribe To Our Newsletter & Stay Updated
